Ankylosing Spondylitis Treatment Market size to Reach USD 10.93 Billion by 2031, Driven by Biologics Adoption

Ankylosing Spondylitis Treatment Market Overview

According to Mordor Intelligence, the ankylosing spondylitis treatment market size is estimated at USD 7.67 billion in 2026 and is expected to reach USD 10.93 billion by 2031, growing at a CAGR of 7.32% during the forecast period.

This ankylosing spondylitis treatment market growth is supported by better recognition of axial spondyloarthritis as a defined condition, which has helped clinicians diagnose patients earlier and more accurately. The growing use of MRI in clinical settings, along with AI-supported imaging tools, is helping physicians identify inflammation at earlier stages.

Another factor influencing the ankylosing spondylitis treatment market forecast is improved reimbursement policies across developed and emerging economies. Patients now have greater access to biologics and biosimilars, reducing the financial burden associated with long-term therapy. This is helping broaden the reach of the ankylosing spondylitis treatment industry.

Key Ankylosing Spondylitis Treatment Market Trends

Growing Adoption of Biologics

The ankylosing spondylitis treatment market is increasingly driven by the use of biologics, especially TNF inhibitors and IL-17 inhibitors. These therapies are widely used to control inflammation and improve patient quality of life. Their proven effectiveness keeps them at the forefront of treatment strategies. As a result, they continue to hold a strong share in the overall market.

Rise of Oral JAK Inhibitors

Another important trend is the growing popularity of oral JAK inhibitors. These medications offer a convenient alternative to injectable treatments, making them more patient-friendly. The ease of oral administration is influencing prescribing decisions among healthcare providers. This shift is expected to support continued market growth in the coming years.

Impact of Biosimilars and Pricing

Biosimilars are playing a key role in shaping the market by increasing competition. This has led to more competitive pricing, especially in developed regions. Lower costs are improving access to advanced treatments for a larger patient population. As affordability improves, the overall market size continues to expand steadily.

Expansion of Healthcare Access

Improving healthcare infrastructure, particularly in Asia Pacific, is boosting market demand. The rise in hospitals and trained specialists is helping in early diagnosis and better treatment access. Additionally, combination therapies and treat-to-target approaches are becoming more common. These factors are collectively driving growth in the ankylosing spondylitis treatment market.

Ankylosing Spondylitis Treatment Market Segmentation

By Drug Class

• NSAIDs

• TNF Inhibitors

• IL-17 Inhibitors

• JAK Inhibitors

• Biosimilars

• Others

By Route of Administration

• Oral

• Sub-cutaneous

• Intravenous

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

By Geography

• North America

• United States

• Canada

• Mexico

• Europe

• Germany

• United Kingdom

• France

• Italy

• Spain

• Rest of Europe

• Asia Pacific

• China

• Japan

• India

• South Korea

• Australia

• Rest of Asia Pacific

• Middle East and Africa

• GCC

• South Africa

• Rest of Middle East and Africa

• South America

• Brazil

• Argentina

• Rest of South America

Key Players in the Ankylosing Spondylitis Treatment Industry

• Novartis AG

• AbbVie Inc.

• Amgen Inc.

• Boehringer Ingelheim International GmbH

• UCB S.A.

Explore more insights on ankylosing spondylitis treatment competitive landscape: https://www.mordorintelligence.com/industry-reports/ankylosing-spondylitis-treatment-market/companies?utm_source=abnewswire

Conclusion

The ankylosing spondylitis treatment market is expected to maintain a steady growth path as awareness, diagnosis, and treatment options continue to improve. The increasing availability of biologics, biosimilars, and oral therapies is expanding treatment choices and supporting ankylosing spondylitis treatment market growth.

At the same time, improvements in healthcare infrastructure and reimbursement policies are helping more patients access advanced treatments. This is particularly evident in emerging regions, where healthcare systems are evolving rapidly. These developments are contributing to a broader ankylosing spondylitis treatment market size and strengthening the overall ankylosing spondylitis treatment industry.

Industry Related Reports

Central Nervous System Stimulant Drugs Market:

The central nervous system stimulant drugs market is growing due to rising prevalence of ADHD and sleep disorders. Increasing awareness, diagnosis rates, and expanding treatment options are further driving market growth.

Get more insights: https://www.mordorintelligence.com/industry-reports/central-nervous-system-stimulant-drugs-market?utm_source=abnewswire

Central Nervous System Therapeutics Market size:

The market is projected to grow from USD 143.32 billion in 2026 to USD 197.35 billion by 2031 at a CAGR of 6.62%. Growth is driven by increasing neurological disorders, advancements in drug development, and rising demand for effective CNS treatments.

Get more insights: https://www.mordorintelligence.com/industry-reports/central-nervous-system-therapeutics-market?utm_source=abnewswire

Hyperhidrosis Treatment Market share:

The market is expected to grow from USD 731.77 million in 2026 to USD 959.12 million by 2031 at a CAGR of 5.56%. Growth is fueled by increasing awareness of excessive sweating conditions and growing demand for effective treatment options.

Get more insights: https://www.mordorintelligence.com/industry-reports/hyperhidrosis-treatment-market?utm_source=abnewswire

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

[email protected] https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email: Send Email
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/